Farallon Capital Management’s Veracyte VCYT Stock Holding History

Farallon Capital Management’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,000	Closed	-$225K	–	184
2026 Q1	$225K	Hold	7,000	–	–	﹤0.01%	137
2025 Q4	$295K	Hold	7,000	–	–	﹤0.01%	112
2025 Q3	$240K	Buy	+7,000	New	+$201K	﹤0.01%	114
2022 Q2	–	Sell	-32,500	Closed	-$896K	–	326
2022 Q1	$896K	Sell	32,500 -158,658	-83%	-$4.54M	﹤0.01%	226
2021 Q4	$7.88M	Buy	191,158 +5,936	+3%	+$262K	0.04%	148
2021 Q3	$8.6M	Buy	+185,222	New	+$8.08M	0.04%	141
2020 Q3	–	Sell	-850,000	Closed	-$22M	–	137
2020 Q2	$22M	Sell	850,000 -525,000	-38%	-$13.1M	0.18%	84
2020 Q1	$33.4M	Buy	1,375,000 +375,000	+38%	+$9.44M	0.29%	53
2019 Q4	$27.9M	Hold	1,000,000	–	–	0.19%	75
2019 Q3	$24M	Buy	1,000,000 +650,000	+186%	+$17.3M	0.18%	68
2019 Q2	$9.98M	Buy	+350,000	New	+$8.74M	0.06%	86

Other funds holding VCYT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Farallon Capital Management's VCYT Position: Q2 2026 in Review

Farallon Capital Management sold out of Veracyte (VCYT) in Q2 2026, closing a stake of 7,000 shares — an estimated $225K sold.

Farallon Capital Management first reported a position in VCYT in Q2 2019 and held it in 11 quarters. The position peaked at $33.4M in Q1 2020. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

Farallon Capital Management reported no remaining Veracyte position as of Q2 2026 after selling out during the quarter.
Farallon Capital Management sold 7,000 Veracyte shares in Q2 2026, an estimated $225K.
Farallon Capital Management first reported a position in Veracyte in Q2 2019 and held it in 11 quarters.
Farallon Capital Management's Veracyte position peaked at $33.4M in Q1 2020.
371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Farallon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.